Mackenzie Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Mackenzie Financial's BMY Position: Q1 2026 in Review
Mackenzie Financial increased its Bristol-Myers Squibb (BMY) stake by 32% in Q1 2026, buying an estimated $20.8M and bringing the position to 1,465,433 shares worth $88.9M. The position accounts for 0.11% of the portfolio, ranked #169.
Mackenzie Financial first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Mackenzie Financial held 1,465,433 shares of Bristol-Myers Squibb worth $88.9M as of Q1 2026.
- Mackenzie Financial bought 357,312 Bristol-Myers Squibb shares in Q1 2026, an estimated $20.8M.
- Bristol-Myers Squibb made up 0.11% of Mackenzie Financial's portfolio in Q1 2026, its #169 holding.
- Mackenzie Financial first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.